Clinical Trials Directory

Trials / Completed

CompletedNCT01512329

Pacing Activity Self-management for Patients With Multiple Sclerosis

Pacing Activity Self-management for Patients With Multiple Sclerosis: Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Vrije Universiteit Brussel · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Given the lack of evidence in support of pacing self-management for patients with musltiple sclerosis (MS), it is examined whether physical behavior and health status of patients with MS improve in response to a pacing self-management program. The effects of pacing will be compared with those observed when applying relaxation therapy to patients with MS.

Detailed description

Up to 50 patients fulfilling the criteria for the diagnosis of multiple sclerosis (MS) will be randomized to either 3 weeks of pacing activity self-management or relaxation therapy. Both treatment groups will receive 3 weekly sessions spread over 3 consecutive weeks. All treatments will be delivered by occupational therapists or physiotherapists. One treatment session lasts for about 45 minutes each.

Conditions

Interventions

TypeNameDescription
BEHAVIORALpacing3 one-on-one sessions weekly for 3 consecutive weeks
BEHAVIORALrelaxation3 one-on-one sessions weekly for 3 consecutive weeks

Timeline

Start date
2011-10-01
Primary completion
2014-02-01
Completion
2014-10-01
First posted
2012-01-19
Last updated
2015-12-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01512329. Inclusion in this directory is not an endorsement.